http://www.cardiffoncology.com
Cardiff Oncology, Inc. Company Intro
Cardiff Oncology is a clinical-stage company with the singular mission of developing new oncology therapeutic options for cancer patients.
Industry
Healthcare
Cardiff Oncology, Inc. Headquaters
11055 Flintkote Avenue
San Diego,92121
United States
Cardiff Oncology, Inc. Share price
17 May 2023 13:01 GMT
$1.7500
0.0 (0.0 %)
Cardiff Oncology, Inc. Market cap
$75.951 M
WMC RANKING
2023
Cardiff Oncology, Inc. # 301
BiotechnologyLatest Cardiff Oncology, Inc. News
29 Nov 2023
Exploring the Colorectal Cancer Pipeline and Clinical Trials ...
In March 2022, ALX Oncology Inc. will begin a Phase II Study (With Safety ... Cardiff Oncology, Genentech, Sumitomo Pharma Oncology, GamaMabs Pharma, Qilu...
29 Nov 2023
Exploring the Colorectal Cancer Pipeline and Clinical Trials: FDA Approvals, Therapies, and Major Companies ...
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Colorectal Cancer pipeline constitutes 145+ key companies continuously...
28 Nov 2023
Insights into Prostate Cancer Market and Epidemiology for ...
... Cardiff Oncology, AstraZeneca, Merck & Co, Clarity Pharmaceuticals, Laekna ... Inc., Ayala Pharmaceuticals, Bracco Diagnostics, Inc., enGene, HOOKIPA Pharma...
WMC Market Score
WMC Market to Revenue Score
Cardiff Oncology, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Cardiff Oncology, Inc. | USD | $370 | $20,774 | $-23,687 | $760M | 301 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Cardiff Oncology, Inc. Social Followers vs Top 4 Industry Competitors
Cardiff Oncology, Inc. Post vs Top 4 Industry Competitors
Cardiff Oncology, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Cardiff Oncology, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Cardiff Oncology, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Cardiff Oncology, Inc. | 0.00 | 2.33 | 0.01 | 0 | 0 | 0 | 1.01 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
